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IDENTIFICATION OF AN INSULIN-RESPONSIVE ELEMENT IN THE RAT
GLUCOSE-6-PHOSPHATE DEHYDROGENASE GENE
Sheri Lynn Holmen, M.S.
Western Michigan University, 1995
The expression of several genes has been shown to be either positively or
negatively regulated by insulin at the transcriptional level, however no single insulin
responsive DNA element has yet been identified. The transcription factors responsible
for stimulation or inhibition of gene expression by insulin also remain to be identified.
In recent years, expression of the gene for glucose-6-phosphate dehydrogenase
(G6PDH) in primary rat hepatocytes has been found to be influenced by hormones
such as insulin, dexamethosone, and glucagon. The molecular mechanism(s) however,
underlying hormonal regulation of G6PDH gene transcription remains to be elucidated.
The focus of this study was to characterize the insulin responsive elements which
exhibit positive regulation of the glucose-6-phosphate dehydrogenase gene by insulin.
In this study, a segment (+57 to -878) of the rat G6PDH promoter region was
cloned into a plasmid containing the luciferase reporter gene. Serial 5' deletions were
used to define minimal sequences required for insulin regulation. The results suggest
that the insulin responsive element(s) within the G6PDH promoter may be located in
the region from -130 to -50. Gel mobility shift assays using the sequence from -130 to
-39 as a probe revealed nuclear factor(s) from primary rat hepatocytes that complexed
with this sequence. Competition for the nuclear factor(s) using unlabeled probe,
determined that this DNA-protein interaction is specific. Deoxyribonuclease I (DNase
I) footprinting revealed a protected region spanning from -126 to -99.
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INTRODUCTION
Genetic Regulatory Mechanisms
Following the discovery and characterization of bacterial operons, many studies
were initiated to locate similar regulatory systems in eukaryotes (Jacob et al., 1961).
While a similar system has been found in yeast, no operons have yet been found in
multicellular eukaryotes. Eukaryotic genetic systems appear to be much more complex
as compared to the less advanced systems in prokaryotes. Eukaryotic cells contain a
greater amount of DNA, the DNA complexes with histones and other proteins to form
chromatin, the genetic information is carried on many chromosomes as opposed to one,
and these chromosomes are surrounded by a nuclear membrane. The processes of
transcription and translation are separated from one another spatially. The transcripts of
eukaryotic genes are modified before transport to the cytoplasm, and many transcribed
sequences never exit the nucleus.

Therefore, regulation of gene expression may

potentially occur at several levels (Klug et al., 1993).
Transcription
The primary level at which gene expression may be controlled is transcription,
the initiation of mRNA synthesis (Latchman, D.S., 1993). Studies utilizing bacteria
and viruses have begun to dissect how transcription is controlled in prokaryotes. This
work has provided paradigms for understanding how transcription is regulated in
multicellular organisms. It has been shown that only a small fraction of the entire
genome of an organism is transcribed in any one cell at any one time. As little as 1 %
of the total DNA may be transcribed in a differentiated cell (Mathews et al., 1990). The
1
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control region in the immediate vicinity of a transcription start site is called the
promoter. Variations in rates of transcription of different genes may be due to
differences in promoter structure. This may direct RNA polymerase II to bind certain
promoters and not others (Alberts et al., 1994).
Initiation of Transcription
In the eukaryotic cell, most of the structural genes (those encoding proteins) are
transcribed by RNA polymerase II. Several accessory proteins to RNA polymerase II
have been found. Some of these proteins identified so far include (TFII)D, A, B, F, E,
H, and J (Roberts et al., 1993). These proteins have been termed basal transcription
factors. The consensus sequence TATA is located 25 bp 5' of the start site and is
thought to bind TFIID (Figure 1). A consensus sequence includes the nucleotides, cis
elements, which occur most frequently at each position when a series of sequences
thought to have similar functions are compared (Mathews et al., 1990).

The

transcription factor TFIID is a complex of proteins which includes the TATA binding
protein (TBP) and associated factors (TAF's).

The minimal required complex for

initiation of transcription appears to include only (TFil)D, B, F and RNA polymerase
II (Buratowski, 1994).

___

GGGCGG---,__

__,

Figure 1. Transcriptional Control Region for a Mammalian Structural Gene.

3
Regulation of Transcription
Extracellular signals may cue the cells to regulate the extent of transcription of
active genes or to turn certain genes on or off. The metabolic capabilities of a cell are
governed by the mechanisms which determine which genes will be transcribed. The
mechanisms and biochemical pathways by which cells regulate transcription are still
unknown for many external stimuli. Ultimately, regulation of transcription by these
signalling pathways depends on factors that interact with DNA in a highly site-spec�fic
manner (Mitchell et al., 1989).
Hormonal Regulation of Transcription
During the development of multicellular organisms, changes in gene expression
are often influenced by external signals such as hormones.• Hormones are defined as
chemical messengers. They are produced by specialized cells and secreted into the
circulation where they interact with specific receptors on target cells to mediate a
response. Evidence that gene expression in eukaryotes is regulated by extracellular
signals was first provided by Ulrich Clever and Peter Karlson in 1960. Clever and
Karlson discovered that the steroid hormone ecdysone induced changes in the puffing
pattern of salivary gland chromosomes of Chironomus tentans (Clever et al., 1960).
Both positive and negative regulation of gene expression by hormones is
possible.

Regions which increase transcription from a distance independent of

orientation are called enhancers or positive regulatory elements.

If transcription is

decreased, the regions are called silencers or negative regulatory elements (O'Brien et
al., 1991).
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Insulin
Two of the hormones involved in regulation of metabolism include the peptides
glucagon and insulin (Mathews et al., 1990). Insulin is a small peptide, 5.8-kDa,
synthesized by the beta cells of the islets of Langerhans in the pancreas. The secretion
of this. hormone into the bloodstream is a tightly controlled process and is dependent on
plasma glucose levels. After eating, plasma glucose levels rise.

This results in

increased secretion of insulin from the beta cells. When glucose levels are low, as in
fasting, insulin levels are also low (Hargrove et al., 1993).

Insulin is known to

regulate the metabolism of most cells.
The functions of insulin in most tissues include the control of lipid, sugar, ion,
ammo acid, and nucleotide metabolism. There are three major sites of metabolic
regulation in target tissues; in the plasma membrane the transport of glucose, ions, and
other fuel substrates is increased, within the cell several enzymes are activated, and in
the nucleus, gene expression is regulated. Table 1 summarizes the biochemical and
physiological actions of insulin (Mathews et al., 1990).
Table 1
Biochemical and Physiological Actions of Insulin
Biochemical Action
1- Cell permeability to glucose and amino acids
1' Glycolysis
1- Glycogen synthesis
'1, Gluconeogenesis
1- Triacylglycerol synthesis
"¥Lipolysis
.J, Protein degredation
1- Protein, DNA, and RNA synthesis

Physiological Action
Signals fed state
1 Fuel Storage
v Blood glucose
1 Cell growth and differentiation
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Insulin Action
The actions of insulin are initiated by the hormone binding to its receptor, a
transmembrane glycoprotein with intrinsic tyrosine kinase activity in its cytoplasmic
domain. Autophosphorylation of the insulin receptor can result in phosphorylation of
insulin receptor substrate (IRS-1) on multiple tyrosine residues. IRS-1 is a principle
substrate of the insulin receptor, and when activated, binds to the SH2-domains of
numerous signal transduction proteins (Kahn et al., 1993). SH2 domains refer to src
homology regions. These regions are highly conserved noncatalytic domains which aid
the docking of proteins to activated tyrosine kinases by recognizing phosphorylated
tyrosine residues. These proteins, shown in Figure 2, include PI 3-Kinase, GRB2,

Nucleus
►

pp70 ------PI 3,-Kinase

Figure 2. Insulin Signaling Cascade.
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Syp, and nck. They couple with IRS-1 to mediate the insulin response which leads to
the activation of genes (Cheatham et al., 1994).

There are several proposed

mechanisms which lead to gene activation: direct phosphorylation of a cytoplasmic
transcription factor; phosphorylation of a cy_toplasrnic protein which results in the
release of a bound transcription factor; activation of a transcription factor by ligand
binding; removal of inhibitory proteins which block· the entry of transcription factors
into the nucleus and; activation of kinases which translocate to the nucleus where they
change the DNA-binding activities of resident transcription factors enabling them to
activate gene expression (Edwards, 1994; Alberts et al., 1994).
Transcription Factors
Transcription factors have been shown to bind to the DNA sequences in the
promoter regions of structural genes. Several transcription factors have been isolated
and identified. The tertiary structure of the DNA binding domain of a transcription
factor suggests a mechanism by which the protein recognizes a specific DNA sequence
and binds to it. DNA binding domains take on several forms. Some of the domains
studied so far include zinc fingers, leucine zippers, and helix-tum-helix motifs (Klug et
al., 1993) (Figure 3). The transcription factor specificity protein 1 (Spl) is an example
of a factor which contains three tandem zinc fingers at its carboxy terminus.

Sp1

activates transcription by first selectively binding to GC box elements (Briggs et al.,
1986) (Figure 1). Other transcription factors which contain zinc finger DNA binding
domains have different DNA sequence specificities.

Therefore, the structural

framework of the binding motif is not the only determinant of binding specificity. Sp1
also contains a glutamine rich domain on its other end (Figure 3). This domain was
found to be an activation domain which interacts with TAFull0. This domain was
found to be essential for Spl to stimulate transcription (Tjian, R. 1995).
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The transcription factor AP-1 selectively binds cis-elements consisting of the
sequence TGACTCA. The proteins c-jun and fos are capable of forming heterodimers
that can bind to AP-1 sites. Homodimerization of c-jun can also bind to AP-1 sites
(Mitchell, et al., 1989). These proteins are encoded by several genes including c-jun,
junB,junD; fos, and fra-1, in mammals (Mitchell et al., 1989) (Figure 1). The similar
DNA binding specificities of these proteins are due to their conserved leucine zipper
DNA binding domains (Figure 3). This DNA-binding motif consists of a regularly
spaced row of leucines on one side of an a-helix which interacts with another set of
leucines on an a-helix to form dimers of the proteins.

Q
Q

AP 1 Leucine Zipper

Sp 1 Zinc Fingers

+

Sp 1 Glutamine-Rich Domain

Helix-Tum-Helix

Figure 3. Structures of Common DNA-Binding Domains. Also included is the Spl
glutamine rich protein binding activation domain.

LITERATURE REVIEW
Insulin Responsive Genes
Although much is known about the initiation of the signal transduction pathway
for insulin, little is known about the proteins or DNA sequences directly involved in the
expression of insulin responsive genes. There are currently over 50 genes known to
respond to ·insulin (O'Brien et al., 1991).

Positive cis-acting insulin rtsponsive

elements (IRE's) have been found in the glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (Nasrin et al., 1990), amylase (Johnson et al., 1993), prolactin (PRL)
(Stanley, 1992), human growth hormone (hGH)(Prager et al., 1990), glucokinase
(Nouspikel et al., 1992), and fatty acid synthase (FAS) (Moustaid et al., 1994) genes
(Table 2).

Negative regulatory elements for insulin have been identified in the

phosphoenolpyruvate carboxykinase (PEPCK) (O'Brien et al., 1990), insulin-like
growth factor binding protein-I (IGFBP-1) (Suwaniekul et al., 1993) and glucagon
Table 2
Sequence Homology in the Promoters of Insulin-Responsive Genes
Gene
GAPDH
Amylase
PRL
hGH
Glucokinase
FAS
PEPCK
IGFBP-1
Glucagon

5'
-461
-168
-106
-287
-83
-71
-416
-110
-268

Sequence
CCCGCCTCTCAGCCTTTGAA
TCAGTTTATTTTGCGTGAGAGT
TCTTAATGACGGAAATAGAT
ATGGCCTGCGG
TGGTTCTTTG
TCAGCCCATGTGGCGTGGCCGC
TGGTGTTTTGACAAC
AGCAAAACAAACTTATTTTGAACAC
TAGTTTTTCACGCCTGACTGAGATTGAAGGG

8

3'
-453
-147
-87
-277
-73
-50
-403
-85
-238
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genes (Philippe, 1991). Consensus cis-acting DNA sequences and trans-acting factors
for insulin have not yet been identified.

Table 2 compares the reported insulin

responsive sequences for several of the genes listed above.

There are many

homologous regions found between the genes listed in Table 2 as indicated by the
underline and boldface type. It remains to be determined if the same sequences are
responsible for both positive and negative regulation of gene expression by insulin.
Table 2 .shows a common element with 4 consecutive thymidine residues, TTTTG,
shared by the amylase, PEPCK, IGFBP-1, glucagon and glucokinase genes.

The

similarity appears to be the strongest between PEPCK and IGFB-1. However, studies
which mutated the glucagon IRE to eliminate the insulin response did not involve this
sequence (Phillippe, J., 1991).
between GAPDH and FAS.

Another common element, TCAGCC, is shared
The glucagon gene contains a similar sequence

TCACGCC.
Experiments done by Wolf et al. in 1994 studied the regulation of FAS by
insulin. · They proposed a 4 bp consensus sequence for insulin induction.
consensus sequence consists of the bases

The

occc;T · The FAS, GAPDH, hGH, and

glucagon genes all contain this consensus sequence. All of the genes except FAS
contain the pattern GCCT. This consensus sequence implies that positive and negative
regulation by insulincan be mediated similarly.
Glucose-6-Phosphate Dehydrogenase
Another gene known to be induced by insulin is glucose-6-phosphate
· dehydrogenase (G6PDH; EC 1.1.1.49). G6PDH is an enzyme found in all mammalian
cells and is responsible for catalyzing the conversion of glucose to
phosphogluconolactone with a concomitant formation of NADPH.

6-

This enzyme
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controls the flow of carbon through the pentose phosphate pathway. The NADPH
produced is important for reductive biosynthesis, such as the synthesis of fatty acids
and steroids, and for maintaining the redox state of the cell. In growing cells, G6PDH
is essential for the production of ribose-5-phosphate for nucleic ?Cid synthesis (Molero
et al., 1994).
G6PDH has been classified as a member of the lipogenic enzyme family. This
family includes enzymes important for hepatic fatty acid synthesis such as fatty acid
synthase, malic enzyme, and acetyl-CoA carboxylase. The process of fatty acid
synthesis is increased by insulin and decreased by glucagon in rat liver. Since the
regulation of these enzymes is coordinated with the rate of fatty acid synthesis, it has
been hypothesized that the metabolic and hormonal factors, like insulin, which regulate
this process also regulate the induction of G6PDH (Manos et al., 1986).
Studies utilizing inta<;:t animals have identified a variety of nutrients and
hormones responsible for regulation of G6PDH in the liver. However, the use of intact
animals makes it difficult to discern the differences between the direct and indirect
effects of these nutrients and hormones on gene expression. The use of primary rat
hepatocytes in culture provides a less complex system which retains the differentiated
phenotype of the intact animal. By culturing these cells in chemically defined medium it
is possible to add specific quantities of the nutrients and hormones, and therefore define
the precise role these factors play in controlling G6PDH gene expression (Kleitzen et
al., 1993).
The primary signal for induction of lipogenic enzyme gene expression,
including G6PDH, is insulin. Insulin induction of G6PDH was first demonstrated in
primary rat hepatocytes by Kurts and Wells in 1981. Subsequent studies showed that
the increase in G6PDH activity was comparable to increases found in specific rnRNA
(Fritz et al., 1986; Manos, 1987). This data suggests that induction of G6PDH gene
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expression by insulin is either the result of increased gene transcription or stabilization
of the mRNA at the post-trancriptional level. Nuclear "run-on" assays employed on
fasted-refed animals have demonstrated that there is a marked increase in G6PDH gene
transcription (Prostko et al. 1989).
To fully investigate this regulation of G6PDH gene expression, a 935 bp
segment of the rat G6PDH promoter region was isolated using the polymerase chain
reaction (PCR).

This fragment was sequenced and characterized revealing a high

percentage of homology with both the human and mouse G6PDH sequences.
Sequence comparison also revealed putative transcriptional regulatory elements (Rank
et al., 1994). The promoter region is GC-rich, a characteristic typical of X-linked
houskeeping genes (Figure 4). While the gene may be considered "houskeeping" in
many tissues, expression of the gene for G6PDH in primary rat hepatocytes has been
found to be influenced by hormones such as dexamethosone, glucagon, and insulin
(Kleitzen et al., 1994).
Objective of the Study
Although insulin has been shown to regulate the expression of several genes

at

the transcription level, no single insulin responsive DNA sequence has yet been
identified. The transcription factors responsible for stimulation or inhibition of gene
expression by insulin also remain to be identified. Therefore, the molecular
mechanism(s) underlying hormonal regulation of gene transcription remains to be
elucidated. Since it is known that insulin stimulates G6PDH gene expression we were
interested in defining the region(s) within the G6PDH promoter responsible for insulin
regulation. Other objectives included determination of insulin kinetics of G6PDH
induction and comparison of insulin response elements with other reported elements to
generate a consensus sequence.
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MG6PDHP Primer
-878 ccagaagtga agagggcagg agcagcggca gaatcggagc tcctaggaaa
C/EBP
Spl
-828 tcctagtcaa gcggtcaccc ttcccttctc agbagtggaa a�ccccactt
'- ------ .J

� - - - - - - - - - - AP-1

r------ �

-778 cggcttccgg tgtcgtaagt gtgggatccg gaagtaaaac acagactcaa
-728 aggcattaat actagagagt taaaactccg aagtgccaca ctctgctcca
94%
-678 aagtcttaga ccgccagcct gcgttggcca gcggaacagc agaatgctcc
-628 ttactgataa acatcacaac tcttataii5i acaatttttt ttttggacag
1-------1
-578 ggtcctacgt agaccagact agcctcgg_a_c_ _t_c_agagatcc acctgccttt
-528 tttccgtcta ctgggattaa agcagtgagt caccatgtcc acactcgctc
AP-2
XRE
OCTl/2
1--------------1
r-------,
ttcaaggcat cgcatcctca ctaaaac���-���q�ctctc
-478 tcaccccatt
---------------428 tgctgccagg cccctactaa gttaaaagtc tagaggaagc tgcgaaactt
-378 gggccccaga agccaaacta gcctcaggaa ggcgtggcta cgtgctaacg
CREB

r------,1

-----------------------------------

-328 gaagtggggt catccgggaa ggtgcagggc cttgggggca gcggaaagct
- ----- 80%
-278 agaccataca ttatggctgg ggagactaag ggaatacagg agaactgagt
CTF/NFl
---CPI
a �gcaagc aagacatcgc gatcgcggca ggggcatcag
-228 ggagctgfac c a
_______ J

'- -------

iGlHC-OSe-,

r�---,

_______ _,

_______ J

-178 ggacggccaa1a gcggagtt cgcgggattg cgcgcgcatt tatctctact
-128 cttctccccc ccctcctccc ccgcactgat agagtagccc gaagctcctc

--------------

-78

._

-28
+23 agatctgtga acgtgtttgg cagcggcaac taaat
�%
�
G6CDNAL Primer

______

_.

84%

Figure 4. Rat G6PDH Promoter DNA Sequence. The transcription start site is denoted
by a + 1. Putative cis-elements are identified. Sequence homology to the
human gene is shown by the dashed underline, and mouse homology is the
solid underline.
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Significance of the Study
Since insulin plays such an important role in the regulation of metabolism, it is
essential to elucidate the mechanisms of insulin action at the molecular level.
Elucidation of the insulin signaling cascade beginning outside of the cell and travelling
deep within the nucleus, will give researchers better insight into the mechanisms of
signal transduction and control of gene expression in multicellular organisms.
Knowledge of these systems will aid in the development of treatments for diseases
ranging from diabetes to cancer.

MATERIALS AND METHODS
PCR Amplification
The polymerase chain reaction (PCR) was utilized to amplify specific regions
within the glucose-6-phosphate dehydrogenase (G6PDH) promoter region.

The

components and final concentration of the reaction mix consisted of 50 µM of each
nucleotide, 50 rnM KCl, 10 rnM Tris (pH 8.3), 0.15 rnM MgC12, 1.0 µM of each
primer and 1.25 units of Taq DNA polymerase (Boehringer Mannheim, Indianapolis,
IN) in a total volume of 50 µI. A hot start procedure was performed. This consisted of
°

°

heating the samples to 95 C for 5.5 minutes, 85 C for 1 minute (at which time the Taq
°

DNA polymerase was added), and 60 C for 4 minutes. The hot start was followed by
°

°

°

30 cycles of 94 C for 1 minute, 60 C for 2 minutes and 72 C for 3 minutes.
Plasmid Construction
The plasmids 935G6PDH-LUC, 627G6PDH-LUC, 187G6PDH-LUC, and
107G6PDH-LUC were constructed in the following way:

Oligonucleotide primers

(Eppendorf, Madison, WI) complementary to bases within the G6PDH promoter
region were designed based on the rat G6PDH promoter region sequence previously
reported (Rank et al., 1994). The primers PSH33 + �ma I and G6CDNAL + Sal I
were used to clone the 935G6PDH-LUC plasmid. The primers contained 5' linkers
specific for the restriction endonucleases Sma I and Sal I allowing for insertion of the
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amplified PCR fragment in the proper orientation between Sma I and Xho I, 5, of the
luciferase gene in the pGL2-Basic vector (Promega, Madison, WI). The 627G6PDH
LUC clone was also constructed using the primers PSH33 + Sma I and G6CDNAL +
Sal I. The amplified 935 bp product was then cleaved with Sna B I and Sal I. This
allowed for the proper insertion of a 627 bp fragment between Sma I and Xho I in the
p-GL2 Basic Vector. (Sna B I and Sma I both generate blunt ends, while Sal I and
Xho I have compatible cohesive ends). The primers FSP4 + Sma I and G6CDNAL +
Sal I were used to amplify the 187 bp fragment. This region of DNA was also inserted
between the Sma I and Xho I restriction sites in the p-GL2 Basic Vector.. The 107 bp
fragment was amplified using the primers G6107 + Mlu I and G6CDNAL + Sal I
(Table 3). The 107 bp fragment was inserted into the p-GL2 Basic Vector between the
°

sites Mlu I and Xho I. The ligation reactions were performed at 14 C overnight. The
ligated vectors were then introduced by transformation into INVaF' competent E. coli
cells (lnvitrogen, San Diego, CA). The plasmid DNA from the E. coli bacteria was
isolated and purified. Clones were verified by PCR and restriction digestion.
Table 3
Oligonucleotide Primers
Name
PSH 33 + Sma I
G6CDNAL + Sal I
FSP4 + Sma I
G6107 +Mlu I
G6AP1 + Sal I
FSP3 + Sma I

Sequence
5,-ttcccccgggccagaagtgaagagggcaggagc-3,
5,-tcgtcgacatttagttgccgctgccaaacacgttcac-3,
5,-gtagcccgggctcttctcccccccctcctc-3,
5,-gtacgcgttcagtcaaagcacacgccct-3,
5,-tcgtcgactgctttgactgagctgaccccgc-3,
5,'-gtagcccggggtggagctgcaccaatgcaa-3,

Location
-878 to -856
+30 to +57
-130 to -111
-50 to -30
-61 to -39
-230 to -210
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Plasmid DNA Preparation
Luria-Bertani (LB) medium containing 50 µg/ml of the antibiotic ampicillin was
inoculated with E. coli bacteria containing the plasmid DNA of interest and grown
°

overnight at 37 C in a shaking incubator. Plasmid DNA was isolated from the bacterial
culture by alkaline lysis (Sambrook et al., 1989) and purified using an ion exchange
column (The Nest Group, Southboro, MA). The purity of the DNA was confirmed by
agarose gel electrophoresis and A260/A280 absorption ratios.
Hepatocyte Isolation and Culture
Hepatocytes were isolated from 8-12 week old, male Sprague-Dawley rats
(Harlan Sprague-Dawley, Indianapolis, IN) by in situ perfusion of the liver via the
hepatic portal vein with 100 U/ml collagenase D (Boehringer Mannheim, Indianapolis,
IN) and 93 U/ml type I-S hyaluronidase (Sigma, St. Louis, MO) in Mg2+ -free Hepes
balanced salt solution as previously described (Elliget et al. 1983). The resulting cell
suspension was centrifuged at 50 x g for 2 min.

The hepatocyte pellets were

resuspended and washed twice in Waymouth's MB 752/1 medium (GIBCO BRL,
Grand Island, NY) containing 0.5% bovine serum albumin (BSA) (Sigma, St. Louis,
MO). A haemocytometer was used to count the hepatocytes and assess viability using
the method of trypan blue dye exclusion. The hepatocytes were plated on 60 mm
collagen-coated culture dishes to a confluency of approximately 90%. Culture substrata
consisted of 5 µg type I collagen from rat tail (Collaborative Biomedical Products,
Bedford, MA). Cultures were incubated in 4 ml Waymouth's MB 752/1 medium with
°

0.5% BSA at 37 C in a humidified environment of 5% CO 2,95% air. The media was
supplemented with 10 mg/ml gentarnicin. After 6 hours, the media was changed to
serum-free Waymouth's medium, and allowed to incubate overnight.
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Transfection
The cells were transfected with a complex consisting of 5 µg of plasmid DNA
and 15 .µg of the cationic lipid (N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethyl
ammonium methylsulfate (DOTAP) as previously described (Holmen et al., 1995).
DOTAP vesicles (Avanti Polar Lipids, Alabaster, AL) were prepared by transferring
1.0 mg of a chloroform solution of DOTAP to a small glass vial and drying under
vacuum for at least 2 hours at room temperature to create a film on the glass vial. One
ml of double distilled water was added to the vial and mixed by vortexing at high speed
for 15 seconds. The DNA lipid complex was diluted to a volume of 250 µl with
serum-free medium, and allowed to sit for 15 minutes at room temperature.

This

complex was added to the cells in culture and incubated in 2 ml serum-free
Waymouth's medium for 2 hours. After this time, the cells were washed and re
incubated in fresh serum-free medium for 36 hours from the start of transfection to
allow for expression of the plasmids. Insulin treated cultures were dosed with 300
ng/ml porcine insulin (a gift from Eli Lilly) immediately after transfection, and allowed
to incubate in serum-free medium for an additional 36 hours from the start of
transfection.
Cell Processing
Primary rat hepatocytes in culture were processed by first removing the media
and then washing the cells twice with sterile phosphate-buffered saline (PBS). The
cells were lysed by adding 400 µl of lX cell culture lysis reagent (Promega, Madison,
WI), for 15 minutes. The cells were then scraped from the plastic culture dishes with a
rubber policeman and transfered to a 1.7 ml eppendorf tube. The samples were
centrifuged at 13,000 x g for 1 minute to pellet debris. The supernatant was transfered
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to a new tube and assayed for protein content, luciferase activity, and G6PDH activity.
A modified Lowry protein assay was utilized to assess protein content in each of the
samples as previously described (Alam, 1992).

Sample concentrations were

determined by using a standard curve of BSA.
Luciferase Assay .
A 20 µl aliquot of cell lysate was added to 100 µl of luciferase assay reagent
(Promega, Madison, WI). The luciferase assay reagent consists of 20 mM Tricine,
1.07 mM (MgCO3)4Mg(OH)2•5H2O, 2.67 mM MgSO4, 0.1 mM EDTA, 33.3 rnM
DTT, 270 µM coenzyme A, 470 µM luciferin, and 530 µM ATP. The reaction was
measured for two-one minute intervals using a scintillation counter. The reaction is
illustrated in Figure 5.
luciferase+luciferin+ATP<---------> luciferase · luciferyl-AMP+PPi
luciferase · luciferyl-AMP+02 ---------> luciferase+oxyluciferin+AMP+CO2+hv
Figure 5. Reaction of Luciferase.
The average of the two-one minute measurements was normalized to the amount of
protein in the sample. Final values are expressed as counts per minute (CPM)/ µg
protein.
G6PDH Assay
G6PDH activity was measured as the rate of change of NADPH absorbance at
340 nm on a Gilford Response spectrophotometer as previously described (Dror et al.,
1970). The reaction mix consisted of 0.38 mM NADP+, 7.1 mM MgC12, and 81 rnM
triethanolarnine (TEA) buffer pH 7.6, combined with 50 µl of cell extract. The reaction
was started by adding 1.2 mM glucose-6-phosphate. The change in absorbance was
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measured over a period of 3 minutes. The specific activity of G6PDH was expressed
as the change in absorbance per minute per mg protein. The reaction is shown in Figure
6.
Glucose-6-Phosphate + NADP+ --------> 6-phosphogluconolactone + NADPH + H+
Figure 6. Reaction of Glucose-6-Phosphate Dehydrogenase.
Nuclei Isolation
Nuclei were isolated from primary rat hepatocytes in culture using a
modification of a protocol previously described (Schibler et al., 1983). Cells from 30
60-mm plates were pooled. After all the cells were harvested, the suspension was
centrifuged at 900 rpm for 5 minutes in a sorval HG4L swinging bucket rotor. The
pellets were collected and homogenized in 0.3 M sucrose, 60 mM KCl, 15 mM NaCl,
15 mM HEPES, pH 7.4, 2 mM EDTA, 0.5 mM EGTA, 0.15 mM spermine, 0.5 rnM
spermidine, 14 mM B-mercaptoethanol, and.0.5% Nonidet P-40. The suspension was
centrifuged at 2500 rpm for 10 minutes after which the pellets were collected and re
· homogenized in a similar buffer as that mentioned above, except it contained 2.0 M
sucrose and no detergent. The nuclei were purified by layering the homogenate over a
cushion of 2.0 M sucrose buffer and centrifuging in a SW 40.1 rotor at 30,000 rpm for
1 hour. The isolated nuclei were resuspended in nuclei storage buffer consisting of
50% glycerol, 50 mM HEPES, pH 7.4, 150 mM NaCl, .1 mM EDTA, 10 rnM
dithiothreitol (DTT), 0.25 mM phenylmethylsulfonyl fluoride (PMSF).

The nuclei

were lysed by adjusting the final NaCl concentration to 300 mM. After a 30 minute
incubation on ice, the nuclei were re-centrifuged at 24,000 x g for 20 minutes. The
supernatant was transferred to a new tube, snap-frozen in dry ice/ethanol, and stored at
°

-70 C until needed.

20
Radioactively Labeled DNA Probe
A 92 bp DNA fragment was amplified using the primers FSP4 +Sma I and
G6AP1 + Sal I. The amplified fragments were separated from their primers on a 3%
agarose gel in Tris-acetate (TAB) buffer, and extracted from the gel using DE81 ion
exchange paper (Whatrnan International, Maidstop.e, England). The 92 bp DNA
°

fragment was cut with the restriction enzyme Sal I overnight at 37 C to generate 5'
overhangs. The 5' overhangs were filled in using the Klenow fragment of E.coli DNA
polymerase I. The reaction mix contained 20 µCi [a- 32P]dCTP, 1 µl of 3 rnM dNTP
°

mix, and 1 U of Klenow in a total volume of 20 µl. The reaction was incubated at 37

C for 30 minutes, and stopped by adding 1 µl of 0.5 M EDTA. The Ap2 consensus
oligonucleotide was 5' end-labeled using [y-32P]ATP.

The reaction mix contained

approximately 2 pmol of DNA, 10 µCi of [y-32P]ATP, 5 Units of T4 polynucleotide
kinase and lX T4 polynucleotide kinase buffer in a total volume of 10 µl. The reaction
°

was incubated at 37 C for 10 minutes and stopped by adding 1 µl of 0.5 M EDTA.
Unincorporated dNTP's were separated from the labeled oligonucleotides by gel
filtration through a Bio-gel P6 column. The protocol used for filling in the 5'
overhangs was modified from General Protocols in Molecular Biology.
Gel Mobility Shift Assay
Protein DNA binding reactions were performed at room temperature in 20 µl' of
14 rnM HEPES, 5.4 rnM EDTA, 7% glycerol, 28.2·rnM Tris-HCl, pH 7.5, 47 mM
NaCl, 3.5 mM MgC12, 7 mM KCl, 0.8 mM B-mercaptoethanol, 0.05% Tween 20, and
2 µg of poly(dl-dC)-poly(dl-dC) unless otherwise stated. The protein/DNA binding
reactions of the positive controls from Promega's gel shift assay system were
performed at room temperature in 10 µl of 2.5 mM EDTA, 20 % glycerol, 50 mM Tris-
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HCl, pH 7.5, 250 mM NaCl, 5 mM MgC12, 2.5 mM DTI, and 0.25 mg/ml poly(dl
dC)'poly(dl-dC). Each reaction contained 20,000 cpm of labeled oligonucleotide and
the indicated amount of nuclear extract. One hundred-fold molar excess unlabeled
probe was added to the reaction mixture prior to the addition of labeled probe for
competition experiments. The reactions were incubated at room temperature for 30
minutes unless otherwise stated. The samples were electrophoresed at 100 volts
through a 4% non-reducing polyacrylamide gel in either high or low ionic strength
buffer. The IX high ionic strength tris-glycine buffer, pH 8.5, was diluted from a 5X
stock consisting of 250 mM Tris-base, 1.9 M glycine, and 10.5 mM EDTA. The low
ionic strength sodium acetate buffer consisted of 6.8 mM Tris-Cl pH 7.9, 3.3 mM
sodium acetate pH 7.9, and 1.0 mM EDTA pH 8.0.

The positive controls from

Promega's gel shift assay system were electrophoresed through 0.5X TBE buffer.
This was diluted from a lOX stock consisting of 890 mM Tris-HCl, pH 8.0, 890 mM
boric acid, and 20 mM EDT A. After electrophoresis, the gels were dried and exposed
to x-ray film. The total distance migrated by the free probe was divided by the distance
migrated by the shifted probe to determine Rr values.
DNA Footprinting
DNase I footprinting was performed by the procedure described by Promega.
The primers G6AP1 and FSP3 were used to amplify the region between -39 and -230
of the G6PDH promoter. This 192 bp DNA fragment was treated with calf intestinal
°

alkaline phosphatase for 1 h at 37 C. The fragment was then isolated by agarose gel
electrophoresis and purified by Geneclean (Bio 101, Vista, CA). The purified fragment
was 5' end-labeled using T4 polynucleotide kinase (Promega, Madison, WI) and
[y 2P]ATP. The probe was cleaved with the restriction enzyme Sal I in order to
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generate a probe which was 5' end-labeled on one strand only.

Binding assays

contained 50 µl of 50 mM Tris-Cl, pH 8.0, 100 mM KCl, 12.5 mM MgC12, 1.0 rnM
EDTA, 20 % glycerol, 1.0 mM DTT, 0.5- 1.0 ng of probe, and 30 µg of nuclear
extract. After a 10 minute incubation on ice, 50 µl of 5 mM CaC12 and 10 mM MgC12
were added followed by the addition of 0.3 unit of RQl RNase-free DNase I
(Promega, Madison, WI). The reaction was stopped after 1 minute by the addition of
90 µl of 200 mM NaCl, 30 mM EDTA, pH 8.0, 1 % SDS, and 100 µg/ml poly (dl
dC)-poly

(dl-dC).

The

reaction

was

extracted

with

200

µl

of

phenol:chloroform:isoamyl alcohol (equilibrated with TEB buffer and 0.5 M NaCl)
25:24: 1, followed by ethanol precipitation and resuspension in 4 µl of 0.1 M·
NaOH:formamide ( 1:2 v/v), 0. 1 % xylene cyanol, and 0. 1 % bromophenol blue. The
°

samples were denatured by incubation at 95 C for 2 min, after which they were loaded
onto a 6 % polyacrylarnide, 8 M urea sequencing gel and run at 1500 V, 60 watts in
°

TBE lX buffer for lh 45 min. The gel was autoradiographed at -70 C.

RESULTS
Expression of G6PDH-Luciferase Fusion Genes by Transient
Transfection of Primary Rat Hepatocytes
G6PDH-Luciferase fusion gene constructs were used in this study to identify
putative insulin regulatory elements within the 5' flanking region of the G6PDH gene.
Sequences between nucleotides -878 and +57 of the G6PDH gene were fused to the
luciferase reporter gene such that transcription of the luciferase gene was directed by the
G6PDH promoter (Figure 7). To examine how insulin exerts its effects on G6PDH
gene expression, a series of 5, deletion.s of the G6PDH promoter were fused to the
luciferase reporter gene and transiently transfected into primary rat hepatocytes
incubated in chemically defined medium. The constructs containing smaller fragments
of the 5' flanking region of G6PDH were named according to the number of nucleotide
bases of the G6PDH promoter they included, i.e. 935G6PDH-LUC, 627G6PDH
LUC, 187G6PDH-LUC, and 107G6PDH-LUC. All of these deletions have a common
3' end at +57.

pGL2-Basic
Vector
With G6PDH
Promoter Insert

Figure 7. p-GL2 Basic Vector With G6PDH Insert.
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Insulin Stimulation of G6PDH-Luciferase Expression
Insulin treatment increased luciferase activity 1.5-2-fold in constructs which
contained sequences ranging from +57 to -130 (Figure 8). No effect of insulin was
observed when plasmids containing G6PDH promoter sequences spanning from +57 to
-50 were transfected into primary rat hepatocytes. These results suggest that the cis
acting DNA sequences that mediate insulin responsiveness in the G6PDH gene may be
located in the proximal promoter between position -130 to -50 ofthe G6PDH promoter.

+57
=

-878�1 ----------93s�b� I

+57
=-,..-..i

-570�1 --------,,621 b� I

+57

-130�1

I-Insulin
C-Control

+57
-50�1
50

G6PDH Promoter Constructs

100

150

200

Relative Activity
(% Control)

Figure 8. Effect ofInsulin on Constructs Containing Deletions oftheG6PDH
Promoter. Hepatocytes were transfected for 2 h with the indicated G6PDH
promoter construct in serum-free medium. Following transfection, the cells
were incubated for 36 h either in the presence (I) or absence (C) of300
ng/ml porcine insulin. The results are expressed as a percentage ofthe
control. Error bars represent standard error ofthe mean. n = 3.
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Basal G6PDH Promoter Activity of 5' Deletion Constructs in Primacy Rat Hepatocytes
The basal promoter activities of the different constructs were determined by
transient transfection into primary rat hepatocytes. Luciferase activities observed with
the different deletions were compared to that of the 935G6PDH-LUC construct.
Deletion of promoter sequences between -50 and -57_0 produced a significant decrease
in the basal promoter activity of G6PDH (Figure 9). This decrease in basal activity
suggests that elements important for basal G6PDH promoter activity are located within
the -570/-50 region. Figure 4 identifies known sequences within this region which are
likely to be binding sites for several important transcription factors; including Sp 1 and
AP-1.
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p-GL2 Basic

G6PDH Constructs in Base Pairs

Figure 9. Basal Activity of the G6PDH Promoter in Primary Rat Hepatocytes
Transfected With G6PDH-LUC Fµsion Genes. Hepatocytes were
transfected for 2 h with the indicated G6PDH promoter construct in serum
free medium. Following transfection the cells were cultured for 36 h. The
results are expressed as a percentage of the 935G6PDH-LUC construct.
Error bars represent standard error of the mean. n = 3.
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Gel Mobility Shift Assays
The gel mobility shift assay was used to detect sequence-specific DNA-binding
proteins . The gel shift assay core system was purchased form Promega and served as a
positive control to aid in the optimization of this assay for G6PDH . This assay core
system included pure AP 2 extract and a consensus AP 2 oligonucleotide which was 5'
end-labeled with [y- 32P]ATP .
Gel Mobility Shift Experiments Using Nuclear Extracts From Primacy Rat Hepatocytes
The gel mobiltiy shift assays using the sequence from - 130 to - 39 of the
G6PDH promoter as a probe allowed for the detection of sequence-specific DNA
binding proteins . Assay conditions were optimized by comparing several different
previously reported DNA/protein binding buffers (Table 4).
Table 4
Comparison of Reported DNA/Protein Binding Buffers
Hepes
EDTA
DTT
Glycerol
Tris-HCl
NaCl
MgCl�
KCl
BSA
B-ME
Nonidet P- 40
Tween 20
Spermidine
Incubation Time

1
l.0rnN
l.0mlV
5%
lOmM
50mM
5.0m.M
50mM

RT, 15'

2

3
4
5
6
12.5 mlV 12.5 mM 14.0mN 15.0mM
2.0mM
.10 mlV l .0mM
5.4mlV
.50mM
2.0mM
2.5 mlV l.0mM
.75mM
20%
13%
5%
7%
15%
40mM
4.0mM 28.2mM
lOOmM
47mM
4.0m.M
3.5 mM
5.0m.M
lOmM 198mM
7.0mM 120mM
100µg/rnl
2 µg/ mJ
.8mM
0.20%
0.05%
4mM
Ice, 1 b 4 C, 20' RT, 15' RT, 30' RT, 20'
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Results from the gel mobility shift assay using the different DNA/protein
binding buffers is shown in Figure 10. Buffers 3 and 5 appear to promote the best
interactions betwe�n the DNA and the nuclear protein and therefore produce the clearest
gel shift when incubated at the temperatures and times indicated in Table 4. Incubation
of the protein/DNA complex on ice for longer periods of time seemed to produce more
streaking in the lanes. Incubation at room temperature or at 4° C for· 15-30 minutes
appears to be optimum.

1

2

3

4

5

6

4

5

Figure 10. Gel Mobility Shift Assay Using Different Binding Buffers.
Thirty µg of nuclear protein from primary rat hepatocytes dosed for 24 h
with 300 ng/ml insulin was incubated with the DNA probe in the indicated
buffer. The DNA and the protein were incubated for the times and
temperatures indicated in Table 3. The numbers indicate the buffer used.
The first lane is the negative control (-). The last two lanes represent
samples incubated in buffers 4 and 5 for 1 h on ice. Samples were run on
a 6 cm x 8 cm, 4 % high ionic strength polyacrylarnide gel at 100 Volts.

Competition Analysis of Factors Binding to a 92 bp G6PDH Probe
in Gel Mobility Shift Assays
Figure 11 shows that nuclear factor(s) from insulin treated primary rat
hepatocytes bind within this sequence. Addition of 100-fold molar excess unlabeled
probe, identical to the labeled probe, resulted in competition for the nuclear factors in
insulin treated cells. Competition for the nuclear factor(s) indicates that this DNA
protein interaction is specific.

1

2

3

4

5

6

7

Figure 11. Gel Mobility Shift Assay Using Primary Hepatic Nuclear Extracts.
Hepatocytes were treated with 300 ng/rnl insulin for 24 h after which
nuclei were isolated. Nuclear extracts were incubated with the 92 bp DNA
probe in buffer 5 for 30 minutes at room temperature. The samples were
then electrophoresed through a 6 cm x 8 cm 4 % polyacrylamide gel in
high ionic strength tris-glycine buffer. Lane 1 is the negative control
Lanes 2, 4, and 6 contain nuclear extracts from hepatocytes not treated
with insulin (control). Lanes 3, 5, and 7 contain nuclear extracts from
hepatocytes treated for 24 h with insulin. Lanes 4 and 5 contain excess
poly dI-dC to eliminate non-specific binding. Lanes 6 and 7 contain 100fold molar excess competitor DNA.
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Time Course of Insulin Action
Initial gel shift assays were done using nuclei from primary rat hepatocytes
which had been treated with insulin for 24 h. Gel mobility shift assays of nuclear
extracts from these cells showed a band with a relative mobility (Rr) of 2. 3.
Experiments were then performed to determine the time course of insulin induction of
G6PDH. Primary rat hepatocytes were treated with 300 ng/ml porcine insulin for 1 h,
3 h, 6 h, 12 h, and 24 h. The extracted nuclei were allowed to complex with the
labeled 92 bp DNA probe in buffer 5 for 30 minutes at room temperature. The samples
were then electrophoresed on a 6 cm x 8 cm_ 4 % polyacrylarnide gel in high ionic
strength electrophoresis buffer. The results of this gel shift assay showed precipitates
of the protein/DNA complexes in the wells of 1 h and 3 h time points. No gel shift was
observed in the lanes of the other time points. Because of this precipitation, a larger gel
apparatus (16 cm x 18 cm) was used to aid movement of the complex through the gel.
Precipitates were still found within the wells, so a lower ionic strength sodium acetate
electrophoresis buffer was used to alter the stringency of the binding. Nuclei extracted
from cells dosed with insulin for 1 h, 6 h, and 24 h, as well as those not dosed at

all

(control) were complexed with the 92 bp DNA probe and subjected to electrophoresis
through a 16 cm x 18 cm polyacrylarnide gel. Figure 12 shows two shifted bands
appearing in the 6 h sample. Band A has an Rr of 1.6, while band B has an Rr of 4. 8.
Both of these bands appear to be successfully competed for using unlabeled probe, and
are therefore thought to be specific interactions. No bands are visible in the other time
points, although a small precipitation does appear in the well of the 24 h sample. The
relative mobilities of bands A and B in Figure 12 appear to be different than those
observed for the 24 h samples run in high ionic strength electrophoresis buffer shown
in Figure 11.
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Figure 12. Gel Mobility Shift Assay to Detennine the Time Course of Insulin
Induction of G6PDH. 30 µg of nuclear protein from primary rat
hepatocytes was complexed with the DNA probe in buffer 5 for 30 minutes
at room temperature. The samples were run on a 16 cm x 18 cm 4 %
polyacrylamide gel in low ionic strength sodium acetate buffer at 100 V.
Lane 1 is the negative control. Lane 2 contains san1ples of nuclear extract
from cells not dosed with insulin (control). Lanes 3, 4, and 5 contain
samples which were dosed for 1 h, 6 h, and 24 h respectively. Lanes 6, 7,
and 8 are identical to lanes 3, 4, and 5 respectively except that they contain
100-fold molar excess competitor DNA.
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DNA Footprint Analysis
DNase I footprinting was used to identify the region(s) within the G6PDH
promoter to which nuclear factor(s) bind. A 192 bp DNA probe (-230 to -39) was 5'

Figure 13. DNase I Footprint Analysis. Lanes 1-5 contain only the 192 bp DNA
probe. Lane 1 was incubated with DNase for 1 min, Lane 2 for 2 min,
Lane 3 for 3 min, Lane 4 for 4 min and Lane 5 for 5 min. Lanes 6-10 are
the same as 1-5 only they also contain 60 µg of nuclear extract.
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end-labeled with [ P]y ATP. Since the probe must be labeled on only one strand, the
32

DNA was cut with the restriction enzyme Sal I such that the 5' label was removed from
the anti-sense strand. This resulted in a radioactive phosphate on the sense strand only.
A DNase activity curve was performed to determine the amount of time required to
completely digest the 192 bp probe.

Figure 13 shows the autoradiograph of this

experiment. Two minutes appeared to be sufficient for the desired cJeavage pattern. In
addition, two protected areas were identified. The footprinted areas correspond to the
regions -126/-99 and -54/-43 in the G6PDH promoter.

Due to protein binding,

hypersensitive regions are found on either side of these protected areas.

DISCUSSION
In primary rat hepatocytes in culture, insulin has been -shown to increase the
enzyme activity and mRNA levels of G6PDH 1.5-2 fold (Nakamura et al., 1982;
Spence et al., 1982; Kleitzen et al., 1986; Manos et ai., 1987). This increase in activity
was shown to be due to increased levels of G6PDH protein. These results suggest that
regulation by insulin is at the transcriptional level (Kleitzen et al., 1987; Manos et al.,
1991). We set out to define the region(s) within the G6PDH gene responsible for
insulin regulation.
Transfection studies using constructs containing serial 5, deletions of the
G6PDH promoter linked to a luciferase reporter gene were used to localize insulin
responsive elements within 935 bp of the G6PDH promoter region. It was important to
ensure that insulin induction of our G6PDH reporter gene constructs was similar to that
observed within the endogenous gene.

In hepatocytes transfected with constructs

containing the G6PDH promoter sequences ranging from -130 to +57, a 1.5-2 fold
increase in luciferase activity was observed in samples treated with 300 ng/ml insulin
(Figure 8).

Therefore, this data is in agreement with previously reported insulin

induced increases observed in endogenous G6PDH enzyme activities. Figure 8 also
demonstrates that the insulin response is no longer present in hepatocytes transfected
with the construct containing the promoter segment ranging from -50 to +57. These
results define the region of insulin responsiveness in the G6PDH gene to be located
between bases -130 and -50.
Using the gel mobility shift assay we identified an insulin-induced DNA-protein
complex binding to the 92 bp DNA probe extending from -130 to -39 in the G6PDH
33
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promoter region.

Incubation of the nuclear extract with excess cold specific

oligonucleotide sequences abolished binding confirming the specificity of the observed
complex formation. Inclusion of excess non-specific DNA sequences (poly dI-dC) did
not compete for the protein, providing further proof that the complex is indeed DNA
sequence specific (Figure 11). Nuclear extracts from hepatocytes not treated with
insulin were complexed with the 92 bp probe as weil, but did not produce a gel shift
similar to that observed with extracts from insulin treated cells. These results confirm
that the gel shift is the result of insulin-induced protein binding. Insulin-induced
protein binding has also been reported for the GAPDH. prolactin and hGH genes
(Nasrin et al., 1990; Stanley, 1992; Prager et al., 1990). In contrast, no differences in
DNA-protein complex formation were detected between non-treated and insulin treated
cells for the FAS or PEPCK genes (Moustaid, et al., 1994; O'Brien et al., 1990).
Moustaid et al. suggest that the binding of proteins mediating insulin regulation of the
FAS or PEPCK genes are not under insulin control. They imply that the proteins
responsible for increased gene expression are already present, and bound to the DNA,
but are not active.
Initial gel shift assays involved the use of nuclear protein from primary rat
hepatocytes which had been treated with insulin for 24 h. These samples were run on a
polyacrylarnide gel in high ionic strength electrophoresis buffer. The

Rr value of the

shifted band was 2.3 (Figure 11). Subsequent studies were done to determine a time
course of insulin action. Hepatocytes were either not treated at all (control) or were
treated with insulin for l h, 3h, or 6h. Due to difficulties in complex formation and
migration, a lower ionic strength polyacrylarnide gel was used (see results).

Two

Rr values of 1.6 and 4.8,

but no

shifted bands were observed in the 6 h sample, with

bands were observed in the 24 h sample (Figure 12). The gel shifts observed with the
6 h time point differ from that observed for the gel shift produced at the 24 h time point
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run in high ionic strength buffer. From these results it was determined that the earlier
time points only formed protein-DNA complexes in the low ionic strength buffer,
whereas the 24 h time point only formed complexes in high ionic strength buffer.
Since DNA-protein complex formation and migration is determined by pH, salt
concentration (ionic strength), complex conformation, and the molecular mass of the
proteins, the differences in band shifting observed in the gel mobility shift assays at 24
h and 6 h may be due simply to the different conditions under which they were run.
However, if the same protein(s) is binding at both the early and late time points, this
does not explain why samples from earlier time points precipitated in the high ionic
strength gel. This d{lta suggests that different proteins with different solubilities are
interacting with the DNA. It may be that there is an early response and a late response.
It is also possible that different proteins recognize an identical sequence. More proteins
may be initially present to aid in the initiation of transcription, but disassociate after a
given amount of time.
Kinetic analysis indicated that formation of the insulin induced complex
required 6 h, and that a complex is still present at 24 h of insulin treatment. Since
formation of an insulin induced complex required at least 6 h, de novo protein synthesis
may be required. These results are in agreement with those reported for insulin
induction of prolactin and hGH gene expression. Stanley et al. reported that induction
of prolactin gene expression by insulin was observed at 5 h and reached its maximum at
24 h. Prager at al. reported that induction of hGH required 8 h and was maintained for
16 h. Using both cyclohexarnide and puromycin as inhibitors of de novo protein
synthesis, Prager et al. showed that de novo protein synthesis is required for increased
gene expression of hGH by insulin. An in vivo study using streptozotocin induced
diabetic mice reported that run on transcription analysis of FAS induced gene
expression by insulin increased to 3.5-fold in 30 minutes. Increases in FAS gene
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expression reached 7-fold by 2 h and were maintained at this level up to 6 h .
Incubation of the cells with cyclohexamide determined that ongoing protein synthesis
was required for increased gene expression of FAS by insulin

(Paulauskis et al.,

1989). Even though the protein which mediates increased gene expression by insulin
appears to be already present (see above), another protein which functions to activate
the bound protein may need to be synthesized. Paulauskis et al. 1989 compared their
observations with those reported for the down-regulation of PEPCK gene expression
by insulin. They stressed that this negative regulation of PEPCK by insulin was at the
transcriptional level, but did not require ongoing protein synthesis in either rat liver in
vivo or in hepatoma cells. Differences in the kinetics of genes either positively or
negatively regulated by insulin may indicate different pathways of regulation.
To determine the location of nuclear factor binding to the G6PDH promoter
region, DNase I footprinting was performed using a singly
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P end-labeled 192 bp

(-230 to -39) probe. Figure 13 shows an autoradiograph of a DNA footprint generated
after different exposure times to DNase I. Two protected areas were observed. One
protected region spans approximately 28 bp, the other approximately 12 bp. Also,
binding of the hepatic nuclear extract to the DNA resulted in hypersensitive sites located
adjacent to the protected regions. The distances migrated by fragments of known
molecular size were used to generate an equation by which the sizes of other fragments
could be determined based on their migration through the gel. Using this method, the
nucleotide sequences of the protected areas were estimated to be between bases -126
and -99, and -43 and -54. The 12 bp protected region appears to correspond to a
putative APl site located in that region. Competition with cold APl however did not
abolish binding in gel shift assays.
The nucleotide sequence of the 28 bp protected region is as follows:

37
5, TCTCCCCCCCCTCCTCCCCCGCACTGAT 3,.

Table 2 shows the sequences

reported to be responsive to insulin in other genes. Comparison of this sequence to the
other sequences in Table 1 reveals little sequence homology.

The complimentary

strand, however, does have some sequence homology to those sequences in Table 1.
The complimentary strand is: 5' ATCAGTGCGGGGGAGGAGGGGGGGGAGA 3 '.
The underlined 4 bp sequence is found in the GAPDH, amylase, and FAS genes.
However, only the sequence found in the GAPDH gene has been linked to insulin
inducible protein binding. Since a consensus sequence was not identified in all of the
genes reported to be insulin responsive, different transcription factors may be involved
in the regulation of these genes by insulin. It is possible that regulation of different
genes by insulin occurs via different mechanisms which may be tissue and/or cell
specific (Edwards, 1994). Further studies to identify the transcription factor(s) known
to interact with this insulin responsive element could lead to a better understanding of
the insulin signaling cascade.
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